Last $163.64 USD
Change Today +0.41 / 0.25%
Volume 1.3M
JAZZ On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Bruce C. Cozadd

Co-Founder, Executive Chairman and Chief Executive Officer, Jazz Pharmaceuticals Public Limited Company
AgeTotal Calculated CompensationThis person is connected to 105 board members in 5 different organizations across 7 different industries.

See Board Relationships
50$8,266,526
As of Fiscal Year 2013

Background*

Mr. Bruce C. Cozadd co-founded Jazz Pharmaceuticals Public Limited Company (also known as Jazzpharmaceuticals, Inc.) in 2003 and has been its Executive Chairman and Chief Executive Officer since January 2012. Mr. Cozadd serves as the Chairman and Chief Executive Officer at Azur Pharma Limited. He served in various executive management positions with ALZA Corporation from 1991 to 2001, including Vice President of Corporate Planning and Analysis. He served as Executive ...

Read Full Background

Corporate Headquarters*

Connaught House
Dublin, Co. Dublin 4

Ireland

Phone: 353 1 634 7800
Fax: --

Board Members Memberships*

Chairman, Chief Executive Officer, Chairman of Jazz Pharmaceuticals, Inc. and Chief Executive Officer of Jazz Pharmaceuticals, Inc.
2000-N/A
Director and Chairman of Audit Committee
2001-Present
Independent Director, Chairman of Audit Committee and Member of Compensation Committee
2005-Present
Director and Member of Compensation Committee
2012-Present
Co-Founder, Executive Chairman and Chief Executive Officer

Education*

BA
Yale University
MBA
Stanford Graduate School of Business

Other Affiliations*

Annual Compensation*

Salary$771,154
Total Annual Compensation$771,154

Stock Options*

Restricted Stock Awards$2,956,500
All Other Compensation$3,622
Exercised Options49,934
Exercised Options Value$1,871,838
Exercisable Options71,747
Exercisable Options Value$5,900,002
Unexercisable Options267,044
Unexercisable Options Value$20,061,817
Total Value of Options$27,833,656
Total Number of Options388,725

Total Compensation*

Total Annual Cash Compensation$1,831,276
Total Short Term Compensation$771,154
Other Long Term Compensation$2,960,122
Total Calculated Compensation$8,266,526
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JAZZ:US $163.64 USD +0.41

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$810.2K
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$868.8K
Rajat Rai Chief Executive Officer
Akorn, Inc.
$250.0K
Carolyn J. Logan Chief Executive Officer, President and Director
Salix Pharmaceuticals Ltd.
$867.5K
Jeffrey M. Yordon Founder, Chairman and Chief Executive Officer
Sagent Pharmaceuticals, Inc.
$615.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JAZZ PHARMACEUTICALS PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.